Functional dyspepsia: drugs for new (and old) therapeutic targets
Tóm tắt
Từ khóa
Tài liệu tham khảo
Talley, 1992, Dyspepsia and dyspepsia subgroups: a population-based study, Gastroenterology, 102, 1259, 10.1016/0016-5085(92)90764-P
Talley, 2001, Therapeutic options in nonulcer dyspepsia, Journal of Clinical Gastroenterology, 32, 286, 10.1097/00004836-200104000-00004
Talley, 1995, Impact of functional dyspepsia on quality of life, Digestive Diseases and Sciences, 40, 584, 10.1007/BF02064375
Nyren, 1992, Economic costs of functional dyspepsia, Pharmacoeconomics, 1, 312, 10.2165/00019053-199201050-00003
Talley, 1988, Non-ulcer dyspepsia: potential causes and pathophysiology, Annals of Internal Medicine, 108, 865, 10.7326/0003-4819-108-6-865
Moayyedi, 2003, Pharmacological interventions for non-ulcer dyspepsia [update of Cochrane Database Syst Rev. 2000;(2):CD001960; PMID: 10796840], Cochrane Database of Systematic Reviews, CD001960
Talley, 2002, The potential role of acid suppression in functional dyspepsia: the BOND, OPERA, PILOT, and ENCORE studies, Gut, 4, iv36, iv41
Talley, 1995, Review article: functional dyspepsia—should treatment be targeted on disturbed physiology?, Alimentary Pharmacology and Therapeutics, 9, 107, 10.1111/j.1365-2036.1995.tb00359.x
Simren, 2003, Acid infusion enhances duodenal mechanosensitivity in healthy subjects, American Journal of Physiology. Gastrointestinal and Liver Physiology, 285, G309, 10.1152/ajpgi.00242.2002
Lee, 2003, Influence of duodenal acidification on the sensorimotor function of the proximal stomach in man, American Journal of Physiology. Gastrointestinal and Liver Physiology
Lu, 1999, Duodenal acid-induced gastric relaxation is mediated by multiple pathways, American Journal of Physiology, 276, G1501
Talley, 1998, Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies), Alimentary Pharmacology and Therapeutics, 12, 1055, 10.1046/j.1365-2036.1998.00410.x
Wong, 2002, Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients, Gut, 51, 502, 10.1136/gut.51.4.502
Moayyedi, 2003, Eradication of Helicobacter pylori for non-ulcer dyspepsia [update of Cochrane Database Syst Rev. 2001;(1):CD002096; PMID: 11279751], Cochrane Database of Systematic Reviews, CD002096
Sjolund, 2003, Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori, Annals of Internal Medicine, 139, 483, 10.7326/0003-4819-139-6-200309160-00011
Vakil, 2003, Gastroesophageal reflux disease and Helicobacter pylori infection, Rev Gastroenterol Disord, 3, 1
Gilvarry, 1997, Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia [comment], Scandinavian Journal of Gastroenterology, 32, 535, 10.3109/00365529709025095
Stanghellini, 1996, Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia, Gastroenterology, 110, 1036, 10.1053/gast.1996.v110.pm8612991
Stanghellini, 1999, Predominant symptoms identify different subgroups in functional dyspepsia, American Journal of Gastroenterology, 94, 2080, 10.1111/j.1572-0241.1999.01281.x
Talley, 1989, Lack of association between gastric emptying of solids and symptoms in nonulcer dyspepsia, Journal of Clinical Gastroenterology, 11, 625, 10.1097/00004836-198912000-00005
Sarnelli, 2003, Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia, American Journal of Gastroenterology, 94, 783, 10.1111/j.1572-0241.2003.07389.x
Fischler, 2003, Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia, Gastroenterology, 124, 903, 10.1053/gast.2003.50155
Talley, 2001, Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia?, American Journal of Gastroenterology, 96, 1422, 10.1111/j.1572-0241.2001.03683.x
Jian, 1989, Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride, Digestive Diseases and Sciences, 34, 657, 10.1007/BF01540334
Duan, 1993, A study of gastric emptying in non-ulcer dyspepsia using a new ultrasonographic method, Scandinavian Journal of Gastroenterology, 28, 355, 10.3109/00365529309090256
Sarin, 1986, Clinical trial on the effect of domperidone on non-ulcer dyspepsia, Indian Journal of Medical Research, 83, 623
Parkman, 1998, Effect of gastric acid suppressants on human gastric motility, Gut, 42, 243, 10.1136/gut.42.2.243
Wiseman, 1994, Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders, Drugs, 47, 116, 10.2165/00003495-199447010-00008
Veldhuyzen van Zanten, 2001, Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis, American Journal of Gastroenterology, 96, 689, 10.1016/S0002-9270(00)02314-5
Wysowski, 1996, Cisapride and fatal arrhythmia, New England Journal of Medicine, 335, 290, 10.1056/NEJM199607253350416
Orihata, 1994, Contractile mechanisms of action of gastroprokinetic agents: cisapride, metoclopramide, and domperidone, American Journal of Physiology, 266, G665
Holtmann, 1993, Functional dyspepsia. Current treatment recommendations, Drugs, 45, 918, 10.2165/00003495-199345060-00005
Orme, 1984, Metoclopramide and tardive dyskinesia in the elderly, British Medical Journal Clinical Research Edition, 289, 397, 10.1136/bmj.289.6442.397
Alizadeh-Naeeni, 2002, Effect of Helicobacter pylori eradication or of ranitidine plus metoclopramide on Helicobacter pylori-positive functional dyspepsia. A randomized, controlled follow-up study, Digestion, 66, 92, 10.1159/000065589
Dumitrascu, 1998, The effect of metoclopramide on antral emptying of a semisolid meal in patients with functional dyspepsia. A randomized placebo controlled sonographic study, Romanian Journal of Internal Medicine, 36, 97
Fumagalli, 1994, Cisapride versus metoclopramide in the treatment of functional dyspepsia. A double-blind comparative trial, Scandinavian Journal of Gastroenterology, 29, 33, 10.3109/00365529409090434
Archimandritis, 1992, Cisapride, metoclopramide, and ranitidine in the treatment of severe nonulcer dyspepsia, Clinical Therapeutics, 14, 553
Ellidokuz, 2003, The effect of metoclopramide on QT dynamicity: double-blind, placebo-controlled, cross-over study in healthy male volunteers, Alimentary Pharmacology and Therapeutics, 18, 151, 10.1046/j.1365-2036.2003.01641.x
Brogden, 1982, Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic, Drugs, 24, 360, 10.2165/00003495-198224050-00002
Weihrauch, 1979, Evaluation of the effect of domperidone on human oesophageal and gastroduodenal motility by intraluminal manometry, Postgraduate Medical Journal, 55, 7
Platteborse, 1979, The effect of domperidone on pyloric activity in dog and in man, Postgraduate Medical Journal, 55, 15
Horowitz, 1985, Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy, Digestive Diseases and Sciences, 30, 1, 10.1007/BF01318363
Troncon, 1994, Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patients, Gut, 35, 327, 10.1136/gut.35.3.327
Tack, 1998, Role of impaired gastric accommodation to a meal in functional dyspepsia, Gastroenterology, 115, 1346, 10.1016/S0016-5085(98)70012-5
Boeckxstaens, 2002, The proximal stomach and postprandial symptoms in functional dyspeptics, American Journal of Gastroenterology, 97, 40, 10.1111/j.1572-0241.2002.05421.x
De Schepper, 2004, Assessment of gastric accomodation: overview and evaluation of current methods, Neurogastroenterology and Motility, 10.1111/j.1365-2982.2004.00497.x
Bouras, 2002, SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography, Gut, 51, 781, 10.1136/gut.51.6.781
Boeckxstaens, 2001, Impaired drinking capacity in patients with functional dyspepsia: relationship with proximal stomach function, Gastroenterology, 121, 1054, 10.1053/gast.2001.28656
Chial, 2002, A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health, Neurogastroenterology and Motility, 14, 249, 10.1046/j.1365-2982.2002.00326.x
Travagli, 2003, Musings on the wanderer: what's new in our understanding of vago-vagal reflexes? III. Activity-dependent plasticity in vago-vagal reflexes controlling the stomach, American Journal of Physiology. Gastrointestinal and Liver Physiology, 284, G180, 10.1152/ajpgi.00413.2002
Takahashi, 1995, Vagal control of nitric oxide and vasoactive intestinal polypeptide release in the regulation of gastric relaxation in rat, Journal of Physiology, 484, 481, 10.1113/jphysiol.1995.sp020680
Desai, 1991, Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid, Nature, 351, 477, 10.1038/351477a0
Coulie, 1999, Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus, American Journal of Physiology, 276, G373
Tack, 2000, Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man, Gut, 46, 468, 10.1136/gut.46.4.468
Cremonini, 2003, Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials, Neurogastroenterology and Motility, 15, 79, 10.1046/j.1365-2982.2003.00389.x
Talley, 2001, A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia, Alimentary Pharmacology and Therapeutics, 15, 525, 10.1046/j.1365-2036.2001.00941.x
Kuo, 2002, Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans, Alimentary Pharmacology and Therapeutics, 16, 225, 10.1046/j.1365-2036.2002.01144.x
Tack, 2002, Influence of tegaserod on proximal gastric sensory and motor function in man, Gastroenterology, 122, A453
Degen, 2001, Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects, Alimentary Pharmacology and Therapeutics, 15, 1745, 10.1046/j.1365-2036.2001.01103.x
Kahrilas, 2000, The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease, Alimentary Pharmacology and Therapeutics, 14, 1503, 10.1046/j.1365-2036.2000.00854.x
Tack, 2002, A phase II placebo controlled randomized trial with tegaserod in functional dyspepsia patients with normal gastric emptying, Gastroenterology, 122, A20
Taggart, 1966, Fatty foods and dyspersia, Lancet, 2, 465
Barbera, 1995, Abnormal sensitivity to duodenal lipid infusion in patients with functional dyspepsia, European Journal of Gastroenterology and Hepatology, 7, 1051, 10.1097/00042737-199511000-00007
Feinle, 1997, Effects of duodenal nutrients on sensory and motor responses of the human stomach to distension, American Journal of Physiology, 273, G721
Feinle, 2000, Relationship between increasing duodenal lipid doses, gastric perception, and plasma hormone levels in humans, American Journal of Physiology. Regulatory Integrative and Comparative Physiology, 278, R1217, 10.1152/ajpregu.2000.278.5.R1217
Moran, 2000, Cholecystokinin and satiety: current perspectives, Nutrition, 16, 858, 10.1016/S0899-9007(00)00419-6
Feinle, 2001, Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia, Gut, 48, 347, 10.1136/gut.48.3.347
Stanghellini, 2003, New developments in the treatment of functional dyspepsia, Drugs, 63, 869, 10.2165/00003495-200363090-00003
Chevlen, 2003, Opioids: a review, Current Pain and Headache Reports, 7, 15, 10.1007/s11916-003-0005-5
Kurz, 2003, Opioid-induced bowel dysfunction: pathophysiology and potential new therapies, Drugs, 63, 649, 10.2165/00003495-200363070-00003
Coffin, 1996, Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans, Alimentary Pharmacology and Therapeutics, 10, 919, 10.1046/j.1365-2036.1996.109280000.x
Read, 1997, Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia, Gut, 41, 664, 10.1136/gut.41.5.664
Dapoigny, 1995, Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study, Digestive Diseases and Sciences, 40, 2244, 10.1007/BF02209014
Delvaux, 1999, The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome, Gastroenterology, 116, 38, 10.1016/S0016-5085(99)70226-X
Delgado-Aros, 2003, Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans, American Journal of Physiology. Gastrointestinal and Liver Physiology, 284, G558, 10.1152/ajpgi.00360.2002
Taguchi, 2001, Selective postoperative inhibition of gastrointestinal opioid receptors, New England Journal of Medicine, 345, 935, 10.1056/NEJMoa010564
Woolf, 1991, The induction and maintenance of central sensitization is dependent on N-methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states, Pain, 44, 293, 10.1016/0304-3959(91)90100-C
Kuiken, 2002, Effect of the low-affinity, noncompetitive N-methyl-d-aspartate receptor antagonist dextromethorphan on visceral perception in healthy volunteers, Alimentary Pharmacology and Therapeutics, 16, 1955, 10.1046/j.1365-2036.2002.01358.x
Bem, 1992, Dextromethorphan. An overview of safety issues, Drug Safety, 7, 190, 10.2165/00002018-199207030-00004
Holzer, 1997, Tachykinins in the gut. Part I. Expression, release and motor function, Pharmacology and Therapeutics, 73, 173, 10.1016/S0163-7258(96)00195-7
Holzer, 1997, Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation, Pharmacology and Therapeutics, 73, 219, 10.1016/S0163-7258(96)00196-9
Poli-Bigelli, 2003, Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America, Cancer, 97, 3090, 10.1002/cncr.11433
Chawla, 2003, Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting, Cancer, 97, 2290, 10.1002/cncr.11320
Fioramonti, 2003, Intestinal anti-nociceptive behaviour of NK3 receptor antagonism in conscious rats: evidence to support a peripheral mechanism of action, Neurogastroenterology and Motility, 15, 363, 10.1046/j.1365-2982.2003.00420.x
Giardina, 2003, Antagonists at the neurokinin receptors-recent patent literature, Drugs, 6, 758
Holzer, 1991, Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons, Pharmacological Reviews, 43, 143
Szallasi, 1995, Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment, Brain Research, 703, 175, 10.1016/0006-8993(95)01094-7
Bortolotti, 2002, The treatment of functional dyspepsia with red pepper, Alimentary Pharmacology and Therapeutics, 16, 1075, 10.1046/j.1365-2036.2002.01280.x
Rodriguez-Stanley, 2000, The effects of capsaicin on reflux, gastric emptying and dyspepsia, Alimentary Pharmacology and Therapeutics, 14, 129, 10.1046/j.1365-2036.2000.00682.x
Kirkup, 2001, Receptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents, American Journal of Physiology. Gastrointestinal and Liver Physiology, 280, G787, 10.1152/ajpgi.2001.280.5.G787
Holzer, 2001, Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain, European Journal of Pharmacology, 429, 177, 10.1016/S0014-2999(01)01319-X
Magni, 1991, The use of antidepressants in the treatment of chronic pain. A review of the current evidence, Drugs, 42, 730, 10.2165/00003495-199142050-00002
Gorelick, 1998, Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans, American Journal of Physiology, 275, G460
Mertz, 1998, Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia, American Journal of Gastroenterology, 93, 160, 10.1111/j.1572-0241.1998.00160.x
Cannon, 1994, Imipramine in patients with chest pain despite normal coronary angiograms [comment], New England Journal of Medicine, 330, 1411, 10.1056/NEJM199405193302003
Jackson, 2000, Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis, American Journal of Medicine, 108, 65, 10.1016/S0002-9343(99)00299-5
Loldrup, 1989, Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study, Psychopharmacology, 99, 1, 10.1007/BF00634443
Tanum, 1996, A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin, Scandinavian Journal of Gastroenterology, 31, 318, 10.3109/00365529609006404
Talley, 2001, Serotoninergic neuroenteric modulators, Lancet, 358, 2061, 10.1016/S0140-6736(01)07103-3
Barbui, 2001, Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials [comment], British Journal of Psychiatry, 178, 129, 10.1192/bjp.178.2.129
Ladabaum, 2002, Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans, Neurogastroenterology and Motility, 14, 395, 10.1046/j.1365-2982.2002.00344.x
Tack, 2003, Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans, Alimentary Pharmacology and Therapeutics, 17, 603, 10.1046/j.1365-2036.2003.01469.x
Chial, 2003, Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans, Clinical Gastroenterology and Hepatology, 1, 211, 10.1016/S1542-3565(03)70038-X
Kuiken, 2003, The selective serotonin reuptake inhibitor fluoxetine does not change rectaql sensitivity and symptoms in patients with irritable bowel syndrome: a double-blind, randomized placebo-controlled study, Clinical Gastroenterology and Hepatology, 1, 219, 10.1016/S1542-3565(03)70039-1
Varia, 2000, Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin, American Heart Journal, 140, 367, 10.1067/mhj.2000.108514
Donker, 1999, Patients with irritable bowel syndrome: health status and use of health care services, British Journal of General Practice, 49, 787
Smart, 1986, Alternative medicine consultations and remedies in patients with the irritable bowel syndrome, Gut, 27, 826, 10.1136/gut.27.7.826
Verhoef, 1990, Use of alternative medicine by patients attending a gastroenterology clinic, CMAJ Canadian Medical Association Journal, 142, 121
Koloski, 2003, Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia, Alimentary Pharmacology and Therapeutics, 17, 841, 10.1046/j.1365-2036.2003.01498.x
Drossman, 1988, Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome, Gastroenterology, 95, 701, 10.1016/S0016-5085(88)80017-9
Sandler, 1984, Symptom complaints and health care seeking behavior in subjects with bowel dysfunction, Gastroenterology, 87, 314, 10.1016/0016-5085(84)90706-6
Koloski, 2001, Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychosocial factors, American Journal of Gastroenterology, 96, 1340, 10.1111/j.1572-0241.2001.03789.x
Hamilton, 2000, A randomized controlled trial of psychotherapy in patients with chronic functional dyspepsia, Gastroenterology, 119, 661, 10.1053/gast.2000.16493